NASDAQ: PROF - Profound Medical Corp.

Rentabilité sur six mois: -1.55%
Secteur: Healthcare

Calendrier des promotions Profound Medical Corp.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.

Plus de détails
The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, palliative pain treatment of bone metastases, and osteoid osteoma. Profound Medical Corp. is headquartered in Mississauga, Canada.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Цена ао 8.15
Выручка 0.0042
EBITDA -0.0132
Число акций ао 0.02118 млрд
P/S 27.02
P/BV 8
EV/EBITDA -8.36
ISIN CA74319B5027
Сайт https://www.profoundmedical.com
Валюта usd
IPO date 2016-06-09
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
Changement de prix par jour: 0% (7.63)
Changement de prix par semaine: +0.778% (7.5711)
Changement de prix par mois: -1.17% (7.72)
Changement de prix sur 3 mois: -23.62% (9.99)
Changement de prix sur six mois: -1.55% (7.75)
Changement de prix par an: -18.31% (9.34)
Evolution du prix sur 3 ans: -44.43% (13.73)
Evolution du prix sur 5 ans: +723.62% (0.9264)
Evolution des prix depuis le début de l'année: -25.8% (10.283)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 26.44 1
P/BV 6.25 1
P/E 0 0
EV/EBITDA -6.28 0
Total: 3.25

Efficacité

Nom Signification Grade
ROA, % -66.6 0
ROE, % -93.79 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.2628 10
Total: 9.8

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 74.55 8
Rentabilité Ebitda, % 111.92 10
Rentabilité EPS, % -1.19 0
Total: 6.6
Plus de détails

Établissements Volume Partager, %
Gagnon Securities, LLC 1541576 6.31
FIL LTD 1200635 4.91
Letko, Brosseau & Associates Inc. 1177850 4.82
Gagnon Advisors, LLC 679296 2.78
AIGH Capital Management LLC 646733 2.65
Raymond James Financial Services Advisors, Inc. 622552 2.55
Timelo Investment Management Inc. 611758 2.5
Royce & Associates LP 564298 2.31
Rosalind Advisors, Inc. 533333 2.18
Royal Bank of Canada 400159 1.64



Superviseur Titre d'emploi Paiement Année de naissance
Dr. Arun Swarup Menawat MBA, Ph.D. Chairman of the Board & CEO 435.87k 1955 (69 années)
Mr. Rashed Dewan Chief Financial Officer 215.18k 1968 (56 années)
Mr. Hartmut Warnken Senior Vice President for Strategic Alliances 226.17k 1973 (51 année)
Dr. Mathieu Burtnyk Chief Operating Officer 215.18k 1982 (42 année)
Mr. Stephen Kilmer Investor Relations N/A
Mr. Jacques F. Cornet VP of International Sales & Marketing N/A 1956 (68 années)
Mr. Matthew Sobczyk C.A., CPA Assistant Corporate Controller N/A
Mr. Levant Tinaz Software Developer N/A
Ms. Abbey Goodman Chief Commercial Officer of Global 1983 (41 année)

Adresse: Canada, Mississauga. ON LW K, 2400 Skymark Avenue - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.profoundmedical.com